Epinephrine self-injectable - kaleoAlternative Names: Allerject; Auvi-Q; e-cue
Latest Information Update: 26 Feb 2016
At a glance
- Originator Intelliject
- Developer kaleo; Sanofi
- Class Antiarrhythmics; Antihaemorrhagics; Antihypotensives; Bronchodilators; Catecholamines; Ethanolamines; Small molecules
- Mechanism of Action Adrenergic receptor agonists
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Marketed Anaphylaxis; Hypersensitivity